2025 June 16;6(6):001-001. doi: 10.37871/jbres2121.
-
Subject area(s):
|
|
|
Opinion ArticleBridging Innovation and Care in Endocrinology: The Evolving Landscape of Metabolic Health
Jessie Evans*
The modern era of medicine is witnessing a transformative shift in how we understand and manage metabolic disorders. Endocrinology, once focused solely on hormonal imbalances, has grown into an interdisciplinary field that integrates clinical endocrinology, metabolic science, nanomedicine, and personalized healthcare.
One of the most pressing challenges globally is Diabetes Mellitus, a chronic condition affecting over 500 million people. It remains a major focus area within our Diabetes Research Section at JBRES. Diabetes is not just a disease of blood sugar—it’s often a gateway to broader metabolic syndromes including obesity, hypertension, and cardiovascular diseases.
Our Metabolism & Endocrinology Section explores how metabolic homeostasis, hormonal signaling, and cellular pathways contribute to disease progression and treatment resistance. The scope of metabolic research now encompasses not just biochemical studies, but also technological innovation that changes patient care.
Enter nanomedicine—a field revolutionizing how drugs are delivered and targeted. At JBRES, our section on Nanomedicine & Biomedical Research highlights work on nanocarriers for insulin delivery, lipid nanoparticle therapies for metabolic inflammation, and gene-based interventions for endocrine disorders.
Meanwhile, the field of clinical endocrinology continues to adopt predictive tools such as AI-based diagnostics, biosensors, and continuous glucose monitors that give practitioners real-time insights into patient status. These innovations, when integrated into routine care, shift the paradigm from reactive to preventive healthcare.
Yet, accessibility to these breakthroughs remains uneven. Our goal at JBRES is to ensure that scientific innovation is not only published—but also reaches healthcare communities worldwide. That’s why we are committed to open access, global indexing, and wide research dissemination through Google Scholar, CrossRef, and more (see full indexing list).
We encourage authors and experts to explore our submission portal and contribute impactful work in the areas of clinical endocrinology, diabetes, metabolism, nanomedicine, and public health.
Together, let’s redefine the future of endocrine care through research, access, and collaboration.
Content Alerts
SignUp to our
Content alerts.
This work is licensed under a Creative Commons Attribution 4.0 International License.
